- Home
- Publications
- Publication Search
- Publication Details
Title
Neoadjuvant and adjuvant chemotherapy in pancreatic cancer
Authors
Keywords
Pancreatic cancer, Neoadjuvant chemotherapy, Adjuvant chemotherapy, Evidence-based medicine, Transcriptomics, Precision medicine
Journal
LANGENBECKS ARCHIVES OF SURGERY
Volume 403, Issue 8, Pages 917-932
Publisher
Springer Nature
Online
2018-11-05
DOI
10.1007/s00423-018-1724-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Oncological Benefits of Neoadjuvant Chemoradiation With Gemcitabine Versus Upfront Surgery in Patients With Borderline Resectable Pancreatic Cancer
- (2018) Jin-Young Jang et al. ANNALS OF SURGERY
- Outcomes After Distal Pancreatectomy with Celiac Axis Resection for Pancreatic Cancer: A Pan-European Retrospective Cohort Study
- (2018) Sjors Klompmaker et al. ANNALS OF SURGICAL ONCOLOGY
- Validation of at least 1 mm as cut-off for resection margins for pancreatic adenocarcinoma of the body and tail
- (2018) T. Hank et al. BRITISH JOURNAL OF SURGERY
- Cancer statistics, 2018
- (2018) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- PET-PANC: multicentre prospective diagnostic accuracy and health economic analysis study of the impact of combined modality 18fluorine-2-fluoro-2-deoxy-d-glucose positron emission tomography with computed tomography scanning in the diagnosis and management of pancreatic cancer
- (2018) Paula Ghaneh et al. HEALTH TECHNOLOGY ASSESSMENT
- Preoperative chemoradiotherapy versus immediate surgery for resectable and borderline resectable pancreatic cancer (PREOPANC-1): A randomized, controlled, multicenter phase III trial.
- (2018) Geertjan Van Tienhoven et al. JOURNAL OF CLINICAL ONCOLOGY
- Unicancer GI PRODIGE 24/CCTG PA.6 trial: A multicenter international randomized phase III trial of adjuvant mFOLFIRINOX versus gemcitabine (gem) in patients with resected pancreatic ductal adenocarcinomas.
- (2018) Thierry Conroy et al. JOURNAL OF CLINICAL ONCOLOGY
- Therapeutic developments in pancreatic cancer: current and future perspectives
- (2018) John P. Neoptolemos et al. Nature Reviews Gastroenterology & Hepatology
- International consensus on definition and criteria of borderline resectable pancreatic ductal adenocarcinoma 2017
- (2018) Shuji Isaji et al. PANCREATOLOGY
- Real-time genomic characterization of advanced pancreatic cancer to enable precision medicine
- (2018) Andrew J Aguirre et al. Cancer Discovery
- Organoid profiling identifies common responders to chemotherapy in pancreatic cancer
- (2018) Hervé Tiriac et al. Cancer Discovery
- Total Neoadjuvant Therapy With FOLFIRINOX Followed by Individualized Chemoradiotherapy for Borderline Resectable Pancreatic Adenocarcinoma
- (2018) Janet E. Murphy et al. JAMA Oncology
- Resectable pancreatic adenocarcinoma neo-adjuvant FOLF(IRIN)OX-based chemotherapy - a multicenter, non-comparative, randomized, phase II trial (PANACHE01-PRODIGE48 study)
- (2018) Lilian Schwarz et al. BMC CANCER
- Optimizing the outcomes of pancreatic cancer surgery
- (2018) Oliver Strobel et al. Nature Reviews Clinical Oncology
- Contrast-enhanced CT in determining resectability in patients with pancreatic carcinoma: a meta-analysis of the positive predictive values of CT
- (2017) Inne Somers et al. EUROPEAN RADIOLOGY
- CONKO-005: Adjuvant Chemotherapy With Gemcitabine Plus Erlotinib Versus Gemcitabine Alone in Patients After R0 Resection of Pancreatic Cancer: A Multicenter Randomized Phase III Trial
- (2017) Marianne Sinn et al. JOURNAL OF CLINICAL ONCOLOGY
- Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial
- (2017) John P Neoptolemos et al. LANCET
- The TRIANGLE operation – radical surgery after neoadjuvant treatment for advanced pancreatic cancer: a single arm observational study
- (2017) Thilo Hackert et al. HPB
- Potentially Curable Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update Summary
- (2017) Alok A. Khorana et al. Journal of Oncology Practice
- LBA18CONKO-006: A RANDOMIZED DOUBLE-BLINDED PHASE IIB-STUDY OF ADJUVANT THERAPY WITH GEMCITABINE + SORAFENIB/PLACEBO FOR PATIENTS WITH R1-RESECTION OF PANCREATIC CANCER
- (2017) M. Sinn et al. ANNALS OF ONCOLOGY
- Locally Advanced Pancreatic Cancer
- (2016) Thilo Hackert et al. ANNALS OF SURGERY
- Outcomes after extended pancreatectomy in patients with borderline resectable and locally advanced pancreatic cancer
- (2016) W. Hartwig et al. BRITISH JOURNAL OF SURGERY
- Borderline resectable pancreatic cancer
- (2016) Thilo Hackert et al. CANCER LETTERS
- Current evidence for the diagnostic value of gadoxetic acid-enhanced magnetic resonance imaging for liver metastasis
- (2016) Masakatsu Tsurusaki et al. HEPATOLOGY RESEARCH
- Effect of Chemoradiotherapy vs Chemotherapy on Survival in Patients With Locally Advanced Pancreatic Cancer Controlled After 4 Months of Gemcitabine With or Without Erlotinib
- (2016) Pascal Hammel et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01)
- (2016) Katsuhiko Uesaka et al. LANCET
- FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis
- (2016) Mustafa Suker et al. LANCET ONCOLOGY
- Pancreatic cancer
- (2016) Jorg Kleeff et al. Nature Reviews Disease Primers
- Total Pancreatectomy for Primary Pancreatic Neoplasms
- (2015) Werner Hartwig et al. ANNALS OF SURGERY
- Radiological and Surgical Implications of Neoadjuvant Treatment With FOLFIRINOX for Locally Advanced and Borderline Resectable Pancreatic Cancer
- (2015) Cristina R. Ferrone et al. ANNALS OF SURGERY
- Neoadjuvant Chemoradiotherapy and Surgery Versus Surgery Alone in Resectable Pancreatic Cancer: A Single-Center Prospective, Randomized, Controlled Trial Which Failed to Achieve Accrual Targets
- (2015) Riccardo Casadei et al. JOURNAL OF GASTROINTESTINAL SURGERY
- Optimal Duration and Timing of Adjuvant Chemotherapy After Definitive Surgery for Ductal Adenocarcinoma of the Pancreas: Ongoing Lessons From the ESPAC-3 Study
- (2014) Juan W. Valle et al. JOURNAL OF CLINICAL ONCOLOGY
- Neoadjuvant chemoradiation therapy with gemcitabine/cisplatin and surgery versus immediate surgery in resectable pancreatic cancer
- (2014) Henriette Golcher et al. STRAHLENTHERAPIE UND ONKOLOGIE
- Borderline resectable pancreatic cancer: A consensus statement by the International Study Group of Pancreatic Surgery (ISGPS)
- (2014) Maximilian Bockhorn et al. SURGERY
- Imaging diagnosis of pancreatic cancer: A state-of-the-art review
- (2014) Eun Sun Lee WORLD JOURNAL OF GASTROENTEROLOGY
- Postoperative Complications Reduce Adjuvant Chemotherapy Use in Resectable Pancreatic Cancer
- (2013) Ryan P. Merkow et al. ANNALS OF SURGERY
- Neoadjuvant Chemotherapy with Gemcitabine and S-1 for Resectable and Borderline Pancreatic Ductal Adenocarcinoma: Results from a Prospective Multi-institutional Phase 2 Trial
- (2013) Fuyuhiko Motoi et al. ANNALS OF SURGICAL ONCOLOGY
- Recent progress in pancreatic cancer
- (2013) Christopher L. Wolfgang et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Adjuvant Chemotherapy With Gemcitabine and Long-term Outcomes Among Patients With Resected Pancreatic Cancer
- (2013) Helmut Oettle et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Modified FOLFIRINOX Regimen With Improved Safety and Maintained Efficacy in Pancreatic Adenocarcinoma
- (2013) Hemchandra Mahaseth et al. PANCREAS
- Response of borderline resectable pancreatic cancer to neoadjuvant therapy is not reflected by radiographic indicators
- (2012) Matthew H. G. Katz et al. CANCER
- Understanding Metastasis in Pancreatic Cancer: A Call for New Clinical Approaches
- (2012) David A. Tuveson et al. CELL
- Open-Label, Multicenter, Randomized Phase III Trial of Adjuvant Chemoradiation Plus Interferon Alfa-2b Versus Fluorouracil and Folinic Acid for Patients With Resected Pancreatic Adenocarcinoma
- (2012) Jan Schmidt et al. JOURNAL OF CLINICAL ONCOLOGY
- Fluorouracil-based Chemoradiation with Either Gemcitabine or Fluorouracil Chemotherapy after Resection of Pancreatic Adenocarcinoma: 5-Year Analysis of the U.S. Intergroup/RTOG 9704 Phase III Trial
- (2011) William F. Regine et al. ANNALS OF SURGICAL ONCOLOGY
- Adjuvant gemcitabine versus NEOadjuvant gemcitabine/oxaliplatin plus adjuvant gemcitabine in resectable pancreatic cancer: a randomized multicenter phase III study (NEOPAC study)
- (2011) Stefan Heinrich et al. BMC CANCER
- Gemcitabine Alone Versus Gemcitabine Plus Radiotherapy in Patients With Locally Advanced Pancreatic Cancer: An Eastern Cooperative Oncology Group Trial
- (2011) Patrick J. Loehrer et al. JOURNAL OF CLINICAL ONCOLOGY
- Detection of Pancreatic Carcinoma and Liver Metastases with Gadoxetic Acid–enhanced MR Imaging: Comparison with Contrast-enhanced Multi–Detector Row CT
- (2011) Utaroh Motosugi et al. RADIOLOGY
- Adjuvant Chemotherapy With Fluorouracil Plus Folinic Acid vs Gemcitabine Following Pancreatic Cancer Resection
- (2010) John P. Neoptolemos et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Preoperative/Neoadjuvant Therapy in Pancreatic Cancer: A Systematic Review and Meta-analysis of Response and Resection Percentages
- (2010) Sonja Gillen et al. PLOS MEDICINE
- Pretreatment Assessment of Resectable and Borderline Resectable Pancreatic Cancer: Expert Consensus Statement
- (2009) Mark P. Callery et al. ANNALS OF SURGICAL ONCOLOGY
- Adjuvant 5-fluorouracil and folinic acid vs observation for pancreatic cancer: composite data from the ESPAC-1 and -3(v1) trials
- (2009) J P Neoptolemos et al. BRITISH JOURNAL OF CANCER
- A randomised phase III trial comparing gemcitabine with surgery-only in patients with resected pancreatic cancer: Japanese Study Group of Adjuvant Therapy for Pancreatic Cancer
- (2009) H Ueno et al. BRITISH JOURNAL OF CANCER
- Longitudinal quality of life data can provide insights on the impact of adjuvant treatment for pancreatic cancer-Subset analysis of the ESPAC-1 data
- (2009) Ross Carter et al. INTERNATIONAL JOURNAL OF CANCER
- Phase III Randomized Comparison of Gemcitabine Versus Gemcitabine Plus Capecitabine in Patients With Advanced Pancreatic Cancer
- (2009) David Cunningham et al. JOURNAL OF CLINICAL ONCOLOGY
- The “Artery First” Approach for Resection of Pancreatic Head Cancer
- (2009) Jürgen Weitz et al. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
- Phase III trial comparing intensive induction chemoradiotherapy (60 Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer. Definitive results of the 2000-01 FFCD/SFRO study
- (2008) B. Chauffert et al. ANNALS OF ONCOLOGY
- Gemcitabine based combination chemotherapy in advanced pancreatic cancer-indirect comparison
- (2008) Asma Sultana et al. BMC CANCER
- Fluorouracil vs Gemcitabine Chemotherapy Before and After Fluorouracil-Based Chemoradiation Following Resection of Pancreatic Adenocarcinoma
- (2008) William F. Regine et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Borderline Resectable Pancreatic Cancer: The Importance of This Emerging Stage of Disease
- (2008) Matthew H.G. Katz et al. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
- Adjuvant Chemoradiation for Pancreatic Cancer: Few Good Data, Much Debate
- (2008) Renee Twombly JNCI-Journal of the National Cancer Institute
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started